[Intravitreal injections of corticoids].
Intravitreal injections of triamcinolone acetonide are today widely performed as a therapeutic tool for a large variety of ocular diseases. The risk of toxicity of the product and its vehicle is quite real and is still at the center of investigations. Complications related to the substance and the technique of injections are already well-known (intraocular pressure rise, cataract, endophthalmitis, pseudo-endophthalmitis, vitreous haemorrhage and retinal detachment). Carefulness and rigor in the indication, realization and follow-up of these injections are therefore mandatory.
Demols
P
P
Service d'Ophtalmologie, Hôpital Erasme, Université Libre de Bruxelles, Bruxelles. paul.demols@erasme.ulb.ac.be
D002386:Cataract / Q000209:etiology; D009877:Endophthalmitis / Q000209:etiology; D005128:Eye Diseases / Q000188:drug therapy*; D006801:Humans; D007267:Injections / Q000009:adverse effects*; D014677:Pharmaceutical Vehicles / Q000009:adverse effects; D012163:Retinal Detachment / Q000209:etiology; D014222:Triamcinolone Acetonide / Q000008:administration & dosage* / Q000009:adverse effects*; D014823:Vitreous Hemorrhage / Q000209:etiology
D014677:Pharmaceutical Vehicles; D014222:Triamcinolone Acetonide